| Sterling Riggs, MD | |
|
1701 Renaissance Blvd, Edmond, OK 73013-3086 | |
| (405) 844-4978 | |
| Not Available |
| Full Name | Sterling Riggs |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 15 Years |
| Location | 1701 Renaissance Blvd, Edmond, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144456005 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 27193 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oklahoma Spine Hospital | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Arthritis Center, P.c. | 0446239743 | 40 |
News Archive
"My mother is driving me crazy!" This phrase is often uttered (or screamed) by people who are taking care of elderly parents. The AgingCare.com message boards are filled with difficult behavior problems by elderly parents: stories of hallucinations, hoarding ... even abuse.
Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.
Meanwhile, Arizona's efforts to create an exchange are morphing into a political hot potato. Also in the news, WellPoint has purchased its own private exchange to compete with the state-run versions envisioned in the health law.
Cellular Dynamics International (CDI) today announced that CDI's development and commercialization of human cardiomyocytes for drug discovery and toxicity testing, based on the work of CDI co-founder and chief scientific officer, James A. Thomson, Ph.D., on induced pluripotent stem cell (iPSCs) technology, have been named to the MIT Technology Review's Annual 10 Emerging Technologies List.
As the COVID-19 virus continues to spread around the globe, studying aerosol and droplet transport within different environments can help establish effective, physics-informed measures for virus mitigation.
› Verified 5 days ago
| Entity Name | Oklahoma Arthritis Center, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528036019 PECOS PAC ID: 0446239743 Enrollment ID: O20040720000063 |
News Archive
"My mother is driving me crazy!" This phrase is often uttered (or screamed) by people who are taking care of elderly parents. The AgingCare.com message boards are filled with difficult behavior problems by elderly parents: stories of hallucinations, hoarding ... even abuse.
Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.
Meanwhile, Arizona's efforts to create an exchange are morphing into a political hot potato. Also in the news, WellPoint has purchased its own private exchange to compete with the state-run versions envisioned in the health law.
Cellular Dynamics International (CDI) today announced that CDI's development and commercialization of human cardiomyocytes for drug discovery and toxicity testing, based on the work of CDI co-founder and chief scientific officer, James A. Thomson, Ph.D., on induced pluripotent stem cell (iPSCs) technology, have been named to the MIT Technology Review's Annual 10 Emerging Technologies List.
As the COVID-19 virus continues to spread around the globe, studying aerosol and droplet transport within different environments can help establish effective, physics-informed measures for virus mitigation.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sterling Riggs, MD 920 Sl Young Blvd, Wp 1290, Oklahoma City, OK 73104-5033 Ph: (405) 271-5504 | Sterling Riggs, MD 1701 Renaissance Blvd, Edmond, OK 73013-3086 Ph: (405) 844-4978 |
News Archive
"My mother is driving me crazy!" This phrase is often uttered (or screamed) by people who are taking care of elderly parents. The AgingCare.com message boards are filled with difficult behavior problems by elderly parents: stories of hallucinations, hoarding ... even abuse.
Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.
Meanwhile, Arizona's efforts to create an exchange are morphing into a political hot potato. Also in the news, WellPoint has purchased its own private exchange to compete with the state-run versions envisioned in the health law.
Cellular Dynamics International (CDI) today announced that CDI's development and commercialization of human cardiomyocytes for drug discovery and toxicity testing, based on the work of CDI co-founder and chief scientific officer, James A. Thomson, Ph.D., on induced pluripotent stem cell (iPSCs) technology, have been named to the MIT Technology Review's Annual 10 Emerging Technologies List.
As the COVID-19 virus continues to spread around the globe, studying aerosol and droplet transport within different environments can help establish effective, physics-informed measures for virus mitigation.
› Verified 5 days ago
Bruce A Mackey, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3957 E Covell Rd, Edmond, OK 73034 Phone: 405-285-7246 Fax: 405-285-7546 | |
Dr. Joshua Marvin Woolard, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2017 W I 35 Frontage Rd Ste 140, Edmond, OK 73013 Phone: 405-757-3630 |